Cargando…
Nomogram construction for predicting survival of patients with non-small cell lung cancer with malignant pleural or pericardial effusion based on SEER analysis of 10,268 patients
Determining the accurate outcome of patients with non-small cell lung cancer (NSCLC) and malignant pleural effusion (MPE) or malignant pleural pericardial effusion (MPCE) at the initial diagnosis remains a challenge. The aim of the present study was to develop an effective nomogram for individualize...
Autores principales: | Tian, Tian, Zhang, Pengpeng, Zhong, Fei, Sun, Cuiling, Zhou, Jian, Hu, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923903/ https://www.ncbi.nlm.nih.gov/pubmed/31897158 http://dx.doi.org/10.3892/ol.2019.11112 |
Ejemplares similares
-
Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion
por: Tian, Tian, et al.
Publicado: (2019) -
Antibody-guided irradiation of malignant pleural and pericardial effusions.
por: Pectasides, D., et al.
Publicado: (1986) -
Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021) -
Recurrent Pericardial and Pleural Effusion due to Pericardial Pleomorphic Mesothelioma
por: Segura-Méndez, Bárbara, et al.
Publicado: (2022) -
Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis
por: Binder, Christina, et al.
Publicado: (2020)